Infectious Diseases News and Research

RSS

Experts to present latest information on paediatric infectious diseases at ESPID 2011

The Annual ESPID Meeting has become the world's largest meeting in the field of Paediatric Infectious Diseases (PID): it provides the latest information on the number one threat to global child health.

1 Jun 2011

Lax tax rules in developing countries hinder aid, Clinton says

In a speech to the OECD last week, Secretary of State Hillary Rodham Clinton said that foreign aid is undermined by lax tax enforcement systems in developing countries and their wealthy citizens who avoid paying taxes, Agence France-Presse reports.

1 Jun 2011

NIH scientists discuss expanded HIV testing and new prevention tools

In the 30 years since the first reported cases of a mysterious illness now known as AIDS, researchers have made extraordinary advances in understanding, treating and preventing the disease.

1 Jun 2011

Scientists find increases in rain and temperature could signal deadly cholera outbreaks months before they strike

With recent deadly cholera outbreaks in Haiti and Cameroon providing the latest indication of a menacingly resurgent disease, scientists have discovered rain and temperature fluctuations in at-risk areas could predict epidemics months in advance, according to a new study published today in the June 2011 issue of the American Journal of Tropical Medicine and Hygiene.

1 Jun 2011

CPS, AAP release joint statement on early childhood caries

Early childhood caries is a serious health problem in North American Indigenous communities that needs immediate attention, say the Canadian Paediatric Society and the American Academy of Pediatrics in a joint statement released today.

30 May 2011

Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrhea

The U.S. Food and Drug Administration today approved Dificid tablets for the treatment of Clostridium difficile-associated diarrhea.

30 May 2011

Recent releases in Global Health

As the G8 summit began in Deauville, France, on Thursday, David Olson, the council's director of policy communications, wrote on the Global Health Council's "Blog 4 Global Health" that "global health is nowhere visible on the agenda," which "is in striking contrast to the final communique of the G8 Muskoka, which devoted a significant amount of space to health" (5/26).

27 May 2011

Molecular mechanism of selected autophagy elucidated

Salmonella is widely prevalent in the animal kingdom. The reason we do not suffer from severe intestinal infections very often is due to our body's defence system, which manages to digest invading bacteria. This is why, generally speaking, a healthy human being will only fall ill if he consumes more than 100.000 salmonella bacteria via a contaminated food source, such as eggs or meat.

27 May 2011

Positive results from CEL-SCI's LEAPS H1N1-activated dendritic cells trial in mice

CEL-SCI Corporation today announced the positive results of efficacy studies in mice of L.E.A.P.S.TM H1N1 activated dendritic cells to treat the H1N1 virus.

27 May 2011

Medicago, USAMRIID enter research collaboration for Ebola vaccine candidate

Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into a research collaboration agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of a plant-based VLP vaccine candidate for the prevention of Ebola. Ebola is a very serious hemorrhagic fever virus for which no licensed treatment or vaccine exists.

26 May 2011

PBS' NewHour examines health insurance for 'urban poor' in Pakistan

PBS' NewsHour special correspondent Saima Mohsin on Monday reported from Pakistan on "an innovative health insurance plan for the urban poor." In Pakistan, 99 percent of the country's low-income population does not have health insurance, and this plan, called Naya Jeevan, "hopes to change that.

26 May 2011

Lytix Biopharma completes two LTX-109 Phase I/IIa studies in MRSA, Gram+ skin infections

The Norwegian pharmaceutical company Lytix Biopharma today announces the successful completion of two Phase I/IIa studies with the topical antimicrobial drug Lytixar - one for nasal decolonisation of MRSA / MSSA bacteria and one for treatment of Gram+ skin infections.

26 May 2011

Recent advances in vaccine development for malaria, TB and HIV/AIDS

Collectively, malaria, TB & HIV/AIDS cause more than five million deaths per year - nearly the entire population of the state of Washington - and represent one of the world's major public health challenges as we move into the second decade of the 21st century.

26 May 2011

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced today that new pre-clinical data for its novel, defensin-mimetic antimicrobial compounds was recently presented at two prestigious scientific meetings, including the American Society of Microbiology.

25 May 2011

Proteros, IP-K partner for structure-based drug discovery services in the field of infectious diseases

Proteros Biostructures GmbH announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under which Proteros will provide structure-based drug discovery services to IP-K.

25 May 2011

Small pox virus destruction pushed back to 2014

The last existing vials of smallpox virus in the U.S. and Russia and due for destruction, have won at least another three years in existence. This is suggesting other countries concur with the U.S. about their value, one leading health official said. The experts and delegates at the annual meeting of the World Health Organization agreed on Tuesday to wait until 2014 to decide on a firm deadline for the final destruction of the lethal virus.

24 May 2011

HIV & hepatitis fears for soldiers at Middle East hospital due to protocol lapse

Australian soldiers and contractors might have been exposed to blood-borne diseases such as hepatitis or HIV after staff at Defense’s main hospital unit in the Middle East failed to sterilize surgical equipment properly.

24 May 2011

Accelerator announces Series A financing of Oncofactor

Accelerator Corporation, a privately held, venture-capital-backed biotechnology investment and development company, announced today the Series A financing of Oncofactor Corporation. This is the twelfth company backed by Accelerator and its first investment based on internal intellectual property developed at Accelerator.

24 May 2011

NIAID team completes analysis of most proteins produced by elephantiasis parasite worm

A team led by Thomas B. Nutman, M.D., of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has completed a large-scale analysis of most of the proteins produced by Brugia malayi, one kind of parasitic worm that causes lymphatic filariasis, or elephantiasis.

24 May 2011

Novel hepatitis C-like virus discovered in dogs

In a study to be published online this week in the Proceedings of the National Academy of Sciences, researchers report the discovery of a novel hepatitis C-like virus in dogs. The identification and characterization of this virus gives scientists new insights into how hepatitis C in humans may have evolved and provides scientists renewed hope to develop a model system to study how it causes disease.

24 May 2011

Infectious Diseases News and Research

Experts to present latest information on paediatric infectious diseases at ESPID 2011

Lax tax rules in developing countries hinder aid, Clinton says

NIH scientists discuss expanded HIV testing and new prevention tools

Scientists find increases in rain and temperature could signal deadly cholera outbreaks months before they strike

CPS, AAP release joint statement on early childhood caries

Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrhea

Recent releases in Global Health

Molecular mechanism of selected autophagy elucidated

Positive results from CEL-SCI's LEAPS H1N1-activated dendritic cells trial in mice

Medicago, USAMRIID enter research collaboration for Ebola vaccine candidate

PBS' NewHour examines health insurance for 'urban poor' in Pakistan

Lytix Biopharma completes two LTX-109 Phase I/IIa studies in MRSA, Gram+ skin infections

Recent advances in vaccine development for malaria, TB and HIV/AIDS

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

Proteros, IP-K partner for structure-based drug discovery services in the field of infectious diseases

Small pox virus destruction pushed back to 2014

HIV & hepatitis fears for soldiers at Middle East hospital due to protocol lapse

Accelerator announces Series A financing of Oncofactor

NIAID team completes analysis of most proteins produced by elephantiasis parasite worm

Novel hepatitis C-like virus discovered in dogs

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News